Status:
COMPLETED
The Effect of Korean Red Ginseng Supplementation on Glucose Control
Lead Sponsor:
Yonsei University
Conditions:
Diabetes
Eligibility:
All Genders
20-70 years
Phase:
PHASE4
Brief Summary
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effect of Korean red ginseng supplementation on glucose control in subjects with impaired fasting g...
Detailed Description
Study participants, who were all aged between 20 and 70, were recruited from health checkup center at Ilsan hospital (Gyeonggi-do, Korea) and the advertisements in local newspaper. After the glucose s...
Eligibility Criteria
Inclusion
- subjects with IFG (100 mg/dL ≤ fasting blood glucose ≤ 125mg/dL), IGT (140mg/dL ≤ 2-h OGTT), or newly-diagnosed T2DM (fasting glucose ≥ 126 mg/dL) were enrolled in this study.
Exclusion
- Exclusion criteria that all selected patients met were: 1) Taking glucose-lowering medications or having insulin injections. 2) Chronic alcoholism or having an evidence or alcoholism. 3) Pregnant or in breast feeding. 4) Having chronic gastrointestinal disorders. 5) Showing signs of nutrient deficiency of malnutrition. 6) Patients with serious kidney problems. 7) Patients with serious liver problems. 8) Patients whose job could be a threat when hypoglycemia occurs. 9) Patients who have experienced the complications such as headache, insomnia, heart palpitations and raised blood pressure after eating red ginseng. 10) Other patients
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01911663
Start Date
November 1 2011
End Date
March 1 2012
Last Update
July 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of clinical Nutrigenetics/Nutrigenomic
Seoul, South Korea, 120-749